5-Amino-1MQ is a selective, small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT), extensively evaluated in metabolic and cellular bioenergetic assays. Designed strictly for laboratory research use only, this compound enables investigators to examine intracellular NAD+ salvage pathways, mitochondrial efficiency, and lipid turnover across diverse preclinical model systems.
5-Amino-1MQ is a selective, small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT), extensively evaluated in metabolic and cellular bioenergetic assays. Designed strictly for laboratory research use only, this compound enables investigators to examine intracellular NAD+ salvage pathways, mitochondrial efficiency, and lipid turnover across diverse preclinical model systems.
5-Amino-1MQ is a small-molecule membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT) used in preclinical research to investigate intracellular NAD+ conservation, mitochondrial bioenergetics, and adipocyte metabolism. In vitro and rodent models utilize 5-Amino-1MQ to evaluate shifts in cellular energy expenditure, lipid accumulation, and metabolic homeostasis without altering feeding behavior or systemic upstream signaling pathways.
Researchers investigating metabolic decline, cellular senescence, and energy substrate utilization frequently implement 5-Amino-1MQ 5mg as a targeted molecular tool. By directly blocking the methyltransferase activity of NNMT, the compound prevents the irreversible consumption of S-adenosylmethionine (SAM) and nicotinamide (NAM), thereby preserving essential cofactors required for oxidative phosphorylation and sirtuin activation.
To understand what 5-Amino-1MQ is used for in laboratory settings, researchers examine its specific interaction with nicotinamide N-methyltransferase. NNMT is a cytosolic enzyme highly expressed in adipose tissue, liver parenchyma, and structural muscle cells, where it catalyzes the methylation of nicotinamide using SAM as a methyl donor. This enzymatic process yields 1-methylnicotinamide (MNA), which is subsequently excreted, effectively removing nicotinamide from the intracellular NAD+ salvage pathway.
Preclinical studies suggest that high NNMT expression correlates with depleted cellular NAD+ pools and reduced mitochondrial oxygen consumption rates. When laboratories introduce 5-Amino-1MQ into cell cultures or animal models, the compound acts as a competitive inhibitor of NNMT. In vitro data indicate that inhibiting this enzyme leads to a significant increase in intracellular NAD+ availability, enhanced sirtuin-1 (SIRT1) signaling, and upregulation of genes regulating mitochondrial biogenesis. Researchers utilize this targeted mechanism to isolate the precise bioenergetic downstream effects of salvage pathway preservation.
In cell culture assays, 5-Amino-1MQ serves as a primary tool for studying adipocyte differentiation, intracellular lipid droplet accumulation, and basal oxygen consumption. Primary pre-adipocytes and immortalized cell lines (such as 3T3-L1) treated with the compound display distinct phenotypical changes during differentiation protocols.
In vitro models routinely measure endpoints such as basal mitochondrial respiration, maximal respiration capability, ATP-linked oxygen consumption, and glycolysis. Investigators studying cellular metabolic reprogramming report that treatment with 5-Amino-1MQ reduces intracellular triglyceride storage without inducing cytotoxic signaling. Furthermore, cell culture studies utilize the molecule to measure changes in histone methylation patterns, as NNMT inhibition alters the ratio of SAM to S-adenosylhomocysteine (SAH), directly influencing epigenetic regulatory mechanisms across diverse cell lineages. Explore our complete research peptides library for complementary compounds applied in cellular signaling assays.
In preclinical animal models, 5-Amino-1MQ is implemented to evaluate systemic energy expenditure, body composition shifts, and skeletal muscle physiology under varying nutritional conditions. High-fat diet (HFD) rodent models are frequently used to observe how localized NNMT inhibition affects whole-body metabolic homeostasis.
Rodent research demonstrates that administration of 5-Amino-1MQ leads to measurable reductions in adipocyte size, decreased epididymal fat mass, and elevated basal metabolic rates without causing alterations in daily caloric intake. Researchers analyzing skeletal muscle tissue from these models observe increased mitochondrial density, enhanced contractile force production, and accelerated recovery markers following functional strain assays. These preclinical findings make 5-Amino-1MQ a critical target for laboratories focusing on sarcopenia, metabolic syndrome, and age-related physical performance decline.
When designing protocols for energy regulation and metabolic research, investigators often evaluate 5-Amino-1MQ alongside other small molecules and peptides that target mitochondrial dynamics or lipid oxidation pathways. Selecting the appropriate research compound depends on whether the biological model requires direct enzymatic inhibition, receptor agonism, or AMP-activated protein kinase (AMPK) activation.
For instance, while 5-Amino-1MQ functions through direct intracellular NNMT inhibition to preserve NAD+, MOTS-c is a mitochondrial-derived peptide that acts primarily by modulating folate cycle dynamics and activating AMPK. In contrast, compounds such as AICAR function as direct AMP mimetics to trigger systemic energy-sensing cascades, whereas growth hormone secretagogues like Tesamorelin influence lipolysis indirectly via pituitary receptor stimulation. The table below outlines how these preclinical compounds differ across primary molecular targets and research endpoints.
Laboratories incorporating 5-Amino-1MQ into experimental protocols rely on standardized quantitative assays to evaluate biological efficacy and mechanism confirmation. Determining the exact response profile requires multi-layered analytical tracking across metabolic and epigenetic markers.
Commonly measured laboratory endpoints include:
• NAD+/NADH Ratios: Measured via enzymatic cycling assays or liquid chromatography-mass spectrometry (LC-MS) to confirm NNMT inhibition efficacy.
• SAM/SAH Ratios: High-performance liquid chromatography (HPLC) quantification of methyl donor preservation within cell lysates.
• Mitochondrial Respiration Metrics: Seahorse XF Analyzer assays tracking oxygen consumption rate (OCR) and extracellular acidification rate (ECAR).
• Gene Expression Profiles: Quantitative RT-PCR tracking downstream markers including SIRT1, PGC-1alpha, UCP1, and PPAR-gamma.
• Morphometric Analysis: Histological staining (such as Oil Red O) quantifying intracellular lipid accumulation in cultured adipocytes or tissue sections.
5-Amino-1MQ is a synthetic small-molecule quinolinium derivative provided as a high-purity lyophilized powder for in vitro and laboratory research applications. Proper solvent selection and handling protocols are vital to maintain compound stability and prevent precipitation in experimental buffers.
Unlike standard hydrophilic peptides, 5-Amino-1MQ exhibits low aqueous solubility in pure water or standard phosphate-buffered saline (PBS) without organic co-solvents. Laboratories typically solubilize the lyophilized powder in dimethyl sulfoxide (DMSO) to prepare concentrated stock solutions, which can subsequently be diluted into culture media or working buffers. For precise calculations regarding molar concentrations and stock dilutions, researchers utilize the PX1 Research reconstitution calculator. Stock solutions should be aliquoted and stored at -80°C to maintain structural integrity and prevent degradation over extended experimental timelines.
Experimental reproducibility in metabolic research relies entirely on the chemical purity, structural identity, and uniformity of the test compound. Contaminants such as residual heavy metals, synthesis intermediates, or bacterial endotoxins can confound cell culture assays and alter metabolic endpoints.
At PX1 Research, all research compounds are manufactured in USA-based, GMP-compliant facilities and undergo rigorous multi-step testing within an independent ISO 17025 accredited laboratory. Every lot of 5-Amino-1MQ undergoes high-performance liquid chromatography (HPLC) to verify purity exceeding 98%, mass spectrometry (MS) to confirm exact molecular weight, and kinetic chromogenic testing to ensure low endotoxin levels. Principal investigators can review batch-specific documentation directly through our public certificate of analysis portal. Institutional buying departments seeking scale quantities for long-term study protocols can coordinate directly through our wholesale lab portal.
What is 5-Amino-1MQ used for in preclinical research?
5-Amino-1MQ is a selective NNMT inhibitor used in laboratory research to study intracellular NAD+ preservation, mitochondrial respiration, adipocyte differentiation, and lipid metabolism in cellular and rodent models.
What enzyme does 5-Amino-1MQ target?
5-Amino-1MQ targets nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme that transfers methyl groups from SAM to nicotinamide, regulating cellular energy metabolism and methyl donor availability.
How does 5-Amino-1MQ increase intracellular NAD+ levels?
By inhibiting NNMT, 5-Amino-1MQ prevents the methylation and subsequent excretion of nicotinamide (NAM). This preserves the substrate required for the NAD+ salvage pathway, leading to elevated intracellular NAD+ concentrations.
What solvents are recommended for reconstituting 5-Amino-1MQ?
5-Amino-1MQ is typically dissolved in dimethyl sulfoxide (DMSO) to create stable stock solutions. Depending on the assay protocol, stock solutions can be diluted into aqueous buffers such as PBS or culture media immediately prior to use.
How does PX1 Research verify the purity of 5-Amino-1MQ?
Every batch of 5-Amino-1MQ from PX1 Research is manufactured in the USA and tested in an ISO 17025 accredited laboratory using HPLC and Mass Spectrometry (MS) to confirm greater than 98% purity, identity, and low endotoxin levels.
Can 5-Amino-1MQ be used in human or veterinary applications?
No. 5-Amino-1MQ is sold strictly as a research compound for in vitro laboratory assays and animal research models. It is not intended for human or veterinary administration, medical treatment, or clinical use.
How does 5-Amino-1MQ differ from MOTS-c and AICAR?
5-Amino-1MQ directly inhibits the NNMT enzyme to block NAD+ degradation. MOTS-c is a mitochondrial-derived peptide targeting the folate cycle and AMPK, while AICAR is an AMP analogue that directly activates AMPK signaling without altering NNMT activity.
What storage conditions are required for 5-Amino-1MQ stock solutions?
Lyophilized powder should be stored at -20°C in a dry environment. Reconstituted stock solutions in DMSO should be aliquoted into single-use vials and stored at -80°C to prevent freeze-thaw degradation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.